Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …

Nonalcoholic fatty liver disease (NAFLD) is now described as the hepatic manifestation of
the metabolic syndrome and is the most frequent chronic liver disease, affecting about one …

Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid
infiltration of the liver, highly prevalent in the general population affecting 25% of adults, with …

Non-alcoholic fatty liver disease (NAFLD) is a major global health threat due to its growing
incidence and prevalence. It is becoming the leading cause of liver disease in addition to its …

NAFLD is the world's most common chronic liver disease, and its increasing prevalence
parallels the global rise in diabetes and obesity. It is characterised by fat accumulation in the …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is rising worldwide, paralleling
the epidemic of obesity. The liver is a key organ for the metabolism of proteins, fats and …

Nonalcoholic fatty liver disease (NAFLD) is a rising epidemic worldwide and will be the
leading cause of cirrhosis, hepatocellular carcinoma, and liver transplant within the next …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
developed world. Simple hepatic steatosis is mild, but the coexistence of steatohepatitis …

Non‐alcoholic fatty liver disease (NAFLD) represents the most common chronic liver
disease. It is characterized by a wide spectrum of hepatic changes, which may progress to …

Lifestyle interventions, namely optimizing nutrition and increasing physical activity, remain
the cornerstone of therapy for non-alcoholic fatty liver disease (NAFLD), as this can lead to …